Cyclical recovery play post-2022-23 insurance ad recession. Q2 revenue +25.9% YoY to $316.9M, contribution margin 14.9%, adj EBITDA guidance path implies ~$126M FY26. Trading 6.7x EV/EBITDA fwd, slight discount vs peer median 7.5x. Base FV ~$12.50 (+14% vs $11.01). Cycle already normalized: further rerating requires evidence of secular growth beyond auto insurance recovery, not just carrier ad-spend rebound. Position sizing appropriate; not a high-conviction value bet.
EV/EBITDA fwd is the appropriate primary method for a cyclical, asset-light marketplace with variable contribution margin — DCF assumes stable growth that history contradicts (2022-23 saw revenue fall 70%). Peer set: pure-play insurance-adjacent digital marketplaces (EVER, QNST, TREE). Sensitivity: ±1x multiple = ±$2.00/sh; ±$15M EBITDA = ±$1.80/sh. ⚠️ Not investment advice.
| Component | Assumption | USD/share |
|---|---|---|
| CORE BUSINESS VALUE (EV) | FY26E EBITDA $126M × 7.5x peer-median multiple = $945M EV / 62.35M shares | +15.15 |
| NET DEBT (subtract) | Cash $23.7M − total debt $176.7M = −$153M / 62.35M shares | −2.45 |
| DILUTION (RSU vesting) | ~1% net dilution p.a. from equity comp partially offset by buybacks: ~-$0.20/sh | −0.20 |
| FV base case | Sum of the rows above | ≈ $12.50 |
Short interest above sector average signals residual skepticism about cycle sustainability and single-carrier concentration risk. Not squeeze territory, but a further beat could produce ~3-5% short-driven upside.
| Item | FY23 | FY24 | FY25 | FY26E | Guidance FY27E |
|---|---|---|---|---|---|
| Revenue ($M) | 440 | 760 | 980 | 1,270 | ~1,400 |
| Adj EBITDA ($M) | 10 | 65 | 87 | 126 | ~140 |
| Adj EBITDA margin | 2.3% | 8.6% | 8.9% | 9.9% | 10.0% |
| Net Income ($M) | −45 | −12 | 28 | 63 | ~90 |
| Diluted EPS ($) | −0.75 | −0.20 | 0.46 | 1.00 | 1.46 |
| FCF ($M) | −15 | 40 | 62 | 95 | ~110 |
| Metric | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 |
|---|---|---|---|---|---|
| Revenue ($M) | 251.7 | 295 | 310 | 295.8 | 316.9 |
| Adj EBITDA margin | 8.8% | 9.5% | 9.6% | 10.6% | 9.2% |
| Net Income ($M) | 3.2 | 7.8 | 15.2 | 18.5 | 41.8 |
| End-of-period cash ($M) | 39 | 44 | 46.9 | 32.1 | 23.7 |
Business model — programmatic insurance marketplace
P&C Insurance (Auto) ~$1,080M FY26E (~85% rev) 🟢 ramping Core segment. Carriers reopened marketing budgets 2024-25 after profitability restoration. Cycle now mature; further growth requires share gains vs GEICO/Progressive direct spend. Health & Life Insurance ~$150M FY26E (~12% rev) 🟡 rebuilding Health segment scaled back after 2023 FTC concerns re: Medicare marketing practices. Rebuild under compliance-first framework; slower growth trajectory. Other Verticals ~$40M FY26E (~3% rev) 🟡 nascent Home services, financial products. Diversification optionality but no material contribution yet.
Legal, regulatory and risk analysis
SWOT analysis
- +Programmatic auction platform with scale advantage in P&C insurance
- +Asset-light model with FCF conversion 70-80% of EBITDA
- +Net debt only 1.2x EBITDA; interest coverage ~9x
- +FCF yield ~14% on market cap at current price
- +Fwd P/E 7.5x on FY27E $1.46 — very cheap on 2027 numbers
- −85% revenue concentration in P&C insurance vertical
- −Contribution margin only 14.9% — limited operating leverage from here
- −History of severe cyclicality (revenue −70% in 2022-23)
- −Health segment structurally impaired post-FTC
- −No dividend; buyback pace modest relative to FCF
- →Insurance cycle could extend into 2027 if loss ratios stay favorable
- →Buyback capacity: $90-100M FCF could retire ~13% of shares annually
- →Medicare/health segment rebuild post-compliance framework
- →Potential re-rating to peer median 7.5x from current 6.7x fwd
- !Auto insurance ad-spend normalization / cyclical peak already in
- !Carrier in-housing of digital marketing (direct-to-consumer shift)
- !AI-driven insurance shopping disintermediation
- !Further FTC / state AG scrutiny of lead-gen practices
Summary by assessment area
- Net debt 1.2x EBITDA
- FCF yield ~14%
- Interest coverage ~9x
- 85% single-vertical concentration
- Cyclical exposure (−70% history)
- Customer concentration in top 3 carriers
- Base upside +14%; bear −40%
- Ratio ~1.6:1 (asymmetry unfavorable)
- Not a high-conviction value trade
Sources: MediaAlpha Q2 2026 earnings release & 10-Q (SEC), Q2 2026 earnings call transcript (Yahoo Finance, Equibles), Simply Wall St analyst forecasts, StockAnalysis.com statistics, MarketBeat insider filings, Leadgen Economy Q1 2026 Scoreboard, KoalaGains peer comparison. Market data — last verified close 2026-09-16: MAX $11.01, market cap ~$687M, 52W range $8.20–$17.50, 62.35M shares outstanding. Short interest ~7.5%. FY26E EBITDA $126M is a Dianalitics estimate derived from H1 actuals + Q3 midpoint guidance + Q4 seasonal run-rate; not company guidance. This document is for informational purposes only and does not constitute financial or investment advice.